INTRODUCTION 43
Escherichia coli is the most frequent pathogen isolated from urinary tract 44 infections (UTIs). The prevalence of this microorganism in uncomplicated UTIs is 45 between 71 and 90% throughout the world (3,18), but the percentage is lower for 46 complicated infections (1,3). The common therapy for UTIs is ampicillin or 47 trimethoprim/sulfamethoxazole. However, the increasing frequency of resistance to 48 these agents (reaching maximum values of >40% and >20%, respectively, in countries 49 like Spain, Portugal, Ireland and Korea (1,17,18)) often necessitates the use of a second 50 antibiotic, such as ciprofloxacin. However, resistance to ciprofloxacin is also increasing 51 in some geographic areas to >20% (17,18). Reasonable alternatives for treating 52 uncomplicated infections are nitrofurantoin and fosfomycin due to the low rates of 53 resistance detected so far (3, 17) . 54
The mechanisms of quinolone resistance have been studied in detail in E. coli 55 strains. They result from both chromosomally-encoded mutations and plasmid-mediated 56 quinolone resistance (10). The first mechanism includes mutations of the target genes, 57 gyrA and gyrB which encode DNA gyrase, and parC and parE encoding Topoisomerase 58 IV (29,35,41,43,44), as well as mutations responsible for a decrease in quinolone 59 permeability, either by increasing the efflux or by decreasing the outer membrane 60 4 mutations are often within the regulatory loci that control efflux pump expression and 68 usually show a 2-to 8-fold increase in the quinolone resistance levels (16). At this step, 69 a multidrug resistance phenotype (MDR) is detected since efflux pumps have a wide 70 range of exportable substrates so that cross-resistance with other antibiotics results 71 (7,10). AcrAB is the main efflux pump described in Enterobacteriaceae which acts in 72 conjunction with TolC (11,32,34). Five regulators have been described so far that exert 73 a role on AcrAB expression (10,13). AcrR, the local repressor encoded upstream of 74 acrA, (20) and AcrS, located upstream of the acrEF operon (13), repress acrAB. Microarray analysis. Total RNA from PS5 and NorE5 was extracted from a mid-118 exponential phase culture (OD600 of 0.6) using Qiagen RNeasy spin columns (Qiagen, 119 Chatsworth, CA). A total of 20 µg of total RNA was labeled with Cy-3-dUTP (RNA 120 from strain PS5) or Cy-5-dUTP (RNA from strain NorE5) in a standard reverse 121 transcriptase (RT) reaction, using Superscript II(+) (Gibco BRL, Carlsbad, CA) with 1 122 µg of random hexamer (Amersham Pharmacia, Piscataway, NJ) primers. performed using 500 ng of RNA at 45ºC for 45 min followed by a standard PCR 157
program. Samples were loaded in a GeneGel Excel (GE Healthcare, Uppsala, Sweden) 158 at 600 V, 25 mA and 15 W for 1.5 h. Gels were stained with a DNA silver staining kit 159 (GE Healthcare, Uppsala, Sweeden) according to the manufacturer's recommendations. 160
Results were corroborated from two independent mRNA extractions and amplifications. Table 3 . 255
Protein analysis using antibodies against AcrB corroborated its increased expression in 256
NorE5. Furthermore, overexpression of TolC was also observed in Western gels (Fig.  257   1) . The AcrAB-TolC pump does not efflux aminoglycosides, consistent with the 258 unchanged MIC for amikacin. 259
The microarrays also revealed significantly increased expression of soxS and marA in 260 NorE5, about 8.4-and 2.8-fold, respectively (Table 3 ). In addition, ompF was decreased 261 7.8-fold, in agreement with the previous study which showed decreased amounts of 262
OmpF in the NorE5 outer membranes (42). The microarrays also showed that mdtG 263 (locus b1053 of E. coli K-12 NC_000913, also known as mdtG) was up-regulated by 264 approximately 2-fold in NorE5 (Table 3) In order to evaluate in vivo the transcriptional activity of the SoxR protein in GC4468, 281 PS5 and NorE5, each strain was transformed with a pRS551 plasmid carrying the SoxS-282 activable fpr::lacZ transcriptional fusion. These strains (GC48-F, P5-F and N5-F) were 283 treated without or with PQ for 1 h and assayed for β-galactosidase activity (Table 4) NorE5 corroborated this finding; mdtG was clearly overexpressed in NorE5 (Fig. 2A) . 297
Similarly, a further RT-PCR analysis of RNA extracts from strains GC4468, DJ901 298 (GC4468 ∆soxRS) and the soxR constitutive strain JTG936 (GC4468 soxR c ) showed that 299 mdtG is also up-regulated in the soxR c strain JTG936 (Fig. 2B ). This suggests that mdtG 300 is a member of the soxS regulon. The results showed clear induction of the promoter in the presence of all three 308 compounds, obtaining maximum activity upon PQ induction (Table 5) . Furthermore, a 309 putative marbox sequence was found within the promoter region, in the backward 310 orientation, 7 bp upstream of the -35 signal and 28 bp upstream of the −10 signal for 311 RNA polymerase (RNP) (Fig. 3) . This marbox is therefore a rare class I marbox like 312 that found in the acnA promoter (21). A second lacZ fusion to the mdtG promoter was 313 made lacking two thirds of the identified marbox sequence (97 bp upstream the ATG) 314 (Fig. 3) , and the corresponding lysogen, strain 4452, was obtained. No significant 315 on July 6, 2017 by guest http://aac.asm.org/ Downloaded from induction of mdtG by PQ, SAL or DIP was observed (Table 5 ). In order to confirm the 316 identity of the marbox detected within the mdtG promoter, binding of the SoxS protein 317 to the 20 bp oligonucleotide of the presumed marbox sequence was performed. As 318 shown in Fig. 4 , SoxS binds to this sequence with a dissociation constant of ~100 nM. 319
Thus, mdtG is a new member of the marA/soxS/rob regulon. However, its role in stress-320
response is yet to be determined. Constitutive expression of SoxS due to an in-frame internal deletion of SoxR of amino 370 acids 136 to 144 (affecting the last 19 amino acids) has been described (31). A second 371 mutation within SoxR, Gly74Arg, found in both PS5 and NorE5, has also been found in 372 several soxS-overexpressing clinical isolates but accompanied by a second mutation 373 within the same locus, Thr38Ser (19). It seems likely that the Gly74Arg change plays 374 little or no role in the overexpression of SoxS since the levels of AcrB expression of 375 PS5 were very similar to those of GC4468 in a Western blotting analysis (data not 376 shown). 377
The most likely explanation is that the frameshift is responsible for constitutive 378 activity of SoxR leading to constitutive expression of soxS and hence an up-regulation 379 of the genes that belong to the regulon. However, due to the fact that soxR and soxS are 380 divergently expressed from the soxRS regulon and the soxS promoter is within the 381 intergenic region (47), the hypothesis was considered that the two nucleotide insertions 382 within soxR may lead to a new promoter responsible for the constitutive expression of 383 soxS. To test this hypothesis, the intergenic region including the partial sequence of 384 soxR where the nucleotide insertions were detected, was amplified from NorE5 and also 385 from PS5. Both PCR products were digested and cloned in pRS551 vector in order to 386 assess its putative promoter activity. The corresponding assays of β-galactosidase 387 activity revealed no significant difference in activity between the sequences (data not 388 shown). Thus, the insertions did not create a new soxS promoter.
The constitutivity of the soxS expression was further demonstrated by 390 monitoring the behavior of an fpr::lacZ transcriptional fusion in strains GC4468, PS5 391 and NorE5. As expected for a regulon promoter, expression of fpr promoter was 5-fold 392 greater in NorE5 than in the parental PS5 (Table 4) . Furthermore, when these cells were 393 treated with PQ to activate SoxR, all three strains showed similar high levels of activity, 394 strongly indicating that the SoxR protein is already in an activated state in NorE5. 395
This study has also revealed a new member of the marA/soxS/rob regulon, 396 mdtG. mdtG is inducible by PQ, SAL and DIP and SoxS binds tightly to the marbox 397 sequence reported within the mdtG promoter. Moreover, disruption of this marbox 398 sequence was accompanied by a loss of the inducibility by all three compounds. The 399
MdtG protein, also named YceE, appears to be a member of the major facilitator 400 superfamily of transporters and, when overexpressed, it has been reported to increase 401 
